For: | Nan YM, Wang RQ, Fu N. Peroxisome proliferator-activated receptor α, a potential therapeutic target for alcoholic liver disease. World J Gastroenterol 2014; 20(25): 8055-8060 [PMID: 25009377 DOI: 10.3748/wjg.v20.i25.8055] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i25/8055.htm |
Number | Citing Articles |
1 |
Shuaixia Feng, Jie Tang, Xia Wei, Zou Lu, Ying Xu, Tong Zhang, Han Han. Swertia cincta and its main active ingredients regulate the PPAR-α pathway in anti-cholestatic liver injury. Journal of Ethnopharmacology 2025; 337: 118956 doi: 10.1016/j.jep.2024.118956
|
2 |
Min‑Jeong Go, Jung‑Ran Noh, Jung Hwan Hwang, Kyoung‑Shim Kim, Dong‑Hee Choi, Jong‑Soo Lee, Yong‑Hoon Kim, Chul‑Ho Lee. Small heterodimer partner deficiency exacerbates binge drinking‑induced liver injury via modulation of natural killer T cell and neutrophil infiltration. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8505
|
3 |
Kyung-Hwan Jegal, Hye-Rim Park, Beom-Rak Choi, Jae-Kwang Kim, Sae-Kwang Ku. Synergistic Protective Effect of Fermented Schizandrae Fructus Pomace and Hoveniae Semen cum Fructus Extracts Mixture in the Ethanol-Induced Hepatotoxicity. Antioxidants 2023; 12(8): 1602 doi: 10.3390/antiox12081602
|
4 |
Zhejin Li, Zejiang Pu, Yuanwei Gao, Min Zhou, Ziheng Zhang, Pengfei Xiao, Jinting Chen, Chengyan Zhou. Integrated serum and liver metabolomics decipher the hepatoprotective mechanisms of mangiferin sodium salt through modulating alcohol metabolism on alcoholic liver disease. Food Bioscience 2024; 61: 104631 doi: 10.1016/j.fbio.2024.104631
|
5 |
I. N. Semenenya, A. H. Shlyahtun, H. F. Raduta. Role of peroxisome proliferator-activated receptors in the control of alcohol dependence and concomitant liver pathology. Proceedings of the National Academy of Sciences of Belarus, Medical series 2019; 16(2): 244 doi: 10.29235/1814-6023-2019-16-2-244-256
|
6 |
Tao Wei, Qiguan Jin. Research trends and hotspots in exercise interventions for liver cirrhosis: A bibliometric analysis via CiteSpace. Medicine 2024; 103(28): e38831 doi: 10.1097/MD.0000000000038831
|
7 |
Yao Du, Chengcheng Yang, Daoyuan Ren, Hongjun Shao, Yan Zhao, Xingbin Yang. Fu brick tea alleviates alcoholic liver injury by modulating the gut microbiota–liver axis and inhibiting the hepatic TLR4/NF-κB signaling pathway. Food & Function 2022; 13(18): 9391 doi: 10.1039/D2FO01547A
|
8 |
I. Gusti Ayu Artini, Agung Wiwiek Indrayani, Gusti Ngurah Bagus Artana, Gusti Made Aman, Ni Wayan Sucindra Dewi. The Activity of Purple Sweet Potato Extract on Antituberculosis-Induced Liver Toxicity. Open Access Macedonian Journal of Medical Sciences 2022; 10(A): 1017 doi: 10.3889/oamjms.2022.8753
|
9 |
Shashi Bala, Timea Csak, Banishree Saha, James Zatsiorsky, Karen Kodys, Donna Catalano, Abhishek Satishchandran, Gyongyi Szabo. The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis. Journal of Hepatology 2016; 64(6): 1378 doi: 10.1016/j.jhep.2016.01.035
|
10 |
Hongmei Yan, Weiyun Wu, Xinxia Chang, Mingfeng Xia, Sicheng Ma, Liu Wang, Jian Gao. Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism. Biology of Sex Differences 2021; 12(1) doi: 10.1186/s13293-020-00344-1
|
11 |
Siva Sundara Kumar Durairajan, Abhay Kumar Singh, Ashok Iyaswamy. Peroxisome proliferator-activated receptor agonists: A new hope towards the management of alcoholic liver disease. World Journal of Gastroenterology 2024; 30(35): 3965-3971 doi: 10.3748/wjg.v30.i35.3965
|
12 |
Aritoshi Koizumi, Kosuke Kaji, Norihisa Nishimura, Shohei Asada, Takuya Matsuda, Misako Tanaka, Nobuyuki Yorioka, Yuki Tsuji, Koh Kitagawa, Shinya Sato, Tadashi Namisaki, Takemi Akahane, Hitoshi Yoshiji. Effects of elafibranor on liver fibrosis and gut barrier function in a mouse model of alcohol-associated liver disease. World Journal of Gastroenterology 2024; 30(28): 3428-3446 doi: 10.3748/wjg.v30.i28.3428
Abstract(174) |
Core Tip(273) |
Full Article(HTML)(1535)
|
Full Article with Cover (PDF)-27476K(51)
|
Audio-2339K(8)
|
Peer-Review Report-254K(22)
|
Answering Reviewers-189K(25)
|
Supplementary Material-514K(27)
|
Full Article (PDF)-27135K(98)
|
Full Article (XML)-172K(27)
|
Times Cited (8)
|
Total Visits (3275)
|
Open
|
13 |
Junying Wei, Qiong Man, Chen Ding, Yanzhen Hu, Mingwei Liu, Hui Li, Feifei Guo, Yi Zhang, Defeng Li, Lei Song, Hongjun Yang, Shihuan Tang. Proteomic Investigations of Transcription Factors Critical in Geniposide-Mediated Suppression of Alcoholic Steatosis and in Overdose-Induced Hepatotoxicity on Liver in Rats. Journal of Proteome Research 2019; 18(11): 3821 doi: 10.1021/acs.jproteome.9b00140
|
14 |
Wei Guo, Wei Zhong, Liuyi Hao, Haibo Dong, Xinguo Sun, Ruichao Yue, Tianjiao Li, Zhanxiang Zhou. Fatty Acids Inhibit LAMP2-Mediated Autophagy Flux via Activating ER Stress Pathway in Alcohol-Related Liver Disease. Cellular and Molecular Gastroenterology and Hepatology 2021; 12(5): 1599 doi: 10.1016/j.jcmgh.2021.07.002
|
15 |
Shu‐Zhen Chen, Yan Ling, Le‐Xing Yu, Yu‐Ting Song, Xiao‐Fei Chen, Qi‐Qi Cao, Han Yu, Can Chen, Jiao‐Jiao Tang, Zhe‐Cai Fan, Yu‐Shan Miao, Ya‐Ping Dong, Jun‐Yan Tao, Satdarshan P.S. Monga, Wen Wen, Hong‐Yang Wang. 4‐phenylbutyric acid promotes hepatocellular carcinoma via initiating cancer stem cells through activation of PPAR‐α. Clinical and Translational Medicine 2021; 11(4) doi: 10.1002/ctm2.379
|
16 |
Yujie Huang, Hedong Lang, Ka Chen, Yong Zhang, Yanxiang Gao, Li Ran, Long Yi, Mantian Mi, Qianyong Zhang. Resveratrol protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis via the PPARα pathway. Applied Physiology, Nutrition, and Metabolism 2020; 45(3): 227 doi: 10.1139/apnm-2019-0057
|
17 |
Yumeng Wang, Shuqiang Li, Zihang Liu, Xuanzheng Li, Yifan Yu, Hao Liu. Identification of PPAR‐related differentially expressed genes liver hepatocellular carcinoma and construction of a prognostic model based on data analysis and molecular docking. Journal of Cellular and Molecular Medicine 2024; 28(8) doi: 10.1111/jcmm.18304
|
18 |
Marit ten Hove, Lena Pater, Gert Storm, Sabine Weiskirchen, Ralf Weiskirchen, Twan Lammers, Ruchi Bansal. The hepatic lipidome: From basic science to clinical translation. Advanced Drug Delivery Reviews 2020; 159: 180 doi: 10.1016/j.addr.2020.06.027
|
19 |
Kai Wang, Jing Shi, Song Gao, Hui Hong, Yuqing Tan, Yongkang Luo. Oyster protein hydrolysates alleviated chronic alcohol-induced liver injury in mice by regulating hepatic lipid metabolism and inflammation response. Food Research International 2022; 160: 111647 doi: 10.1016/j.foodres.2022.111647
|
20 |
Salamah Mohammad Alwahsh, Rolf Gebhardt. Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD). Archives of Toxicology 2017; 91(4): 1545 doi: 10.1007/s00204-016-1892-7
|
21 |
Xiao Hu, Ran Guo, Xu-Guang Zhang. Effects of PPARα against ethanol-induced oxidative stress in mouse gastric mucosa. World Chinese Journal of Digestology 2023; 31(3): 113 doi: 10.11569/wcjd.v31.i3.113
|
22 |
Yishu Wang, Lei Pang, Yanghe Zhang, Jiahui Lin, Honglan Zhou. Fenofibrate Improved Interstitial Fibrosis of Renal Allograft through Inhibited Epithelial-Mesenchymal Transition Induced by Oxidative Stress. Oxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/8936856
|
23 |
Mousa G. Eissa, Carol M. Artlett. The MicroRNA miR-155 Is Essential in Fibrosis. Non-Coding RNA 2019; 5(1): 23 doi: 10.3390/ncrna5010023
|
24 |
Jie Yuan, Hongdan Mo, Jing Luo, Suhong Zhao, Shuang Liang, Yu Jiang, Maomao Zhang. PPARα activation alleviates damage to the cytoskeleton during acute myocardial ischemia/reperfusion in rats. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8771
|
25 |
Mickaël Jouve, Rodolphe Carpentier, Sarra Kraiem, Noémie Legrand, Cyril Sobolewski. MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches?. Cancers 2023; 15(23): 5557 doi: 10.3390/cancers15235557
|
26 |
Mengying Yao, Shaozong Qin, Jiachuan Xiong, Wang Xin, Xu Guan, Shuiqin Gong, Jing Chen, Yong Liu, Bo Zhang, Jinghong Zhao, Yinghui Huang. Oroxylin A ameliorates AKI-to-CKD transition through maintaining PPARα-BNIP3 signaling-mediated mitochondrial homeostasis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.935937
|
27 |
Qi Zhao, Ting Zhang, Xue‐Rong Xiao, Jian‐Feng Huang, Yan Wang, Frank J. Gonzalez, Fei Li. Impaired clearance of sunitinib leads to metabolic disorders and hepatotoxicity. British Journal of Pharmacology 2019; 176(13): 2162 doi: 10.1111/bph.14664
|
28 |
Mohamed Elnagdy, Shirish Barve, Craig McClain, Leila Gobejishvili. cAMP Signaling in Pathobiology of Alcohol Associated Liver Disease. Biomolecules 2020; 10(10): 1433 doi: 10.3390/biom10101433
|
29 |
Bhawana Sharma, Rajesh Dabur. Protective Effects ofTinospora cordifoliaon Hepatic and Gastrointestinal Toxicity Induced by Chronic and Moderate Alcoholism. Alcohol and Alcoholism 2016; 51(1): 1 doi: 10.1093/alcalc/agv130
|
30 |
Ashi Mittal, Nishu Choudhary, Sudrishti Chaudhary, Anupama Kumari, Archana Rastogi, Guresh Kumar, Jaswinder Singh Maras, Shiv K Sarin, Shvetank Sharma. Ethanol with thioacetamide murine model of alcoholic liver disease identifies hepatic pathways as targets for the human disease. Annals of Hepatology 2025; 30(1): 101565 doi: 10.1016/j.aohep.2024.101565
|